Pipeline
Pipeline Overview

Our Development Programs

Program (click indication for details)
Preclinical
Phase 1
Phase 2
Phase 3
NDA / MAA Approved

ADASUVE®: Staccato loxapine

To see full prescribing information, including boxed warning, visit www.ADASUVE.com or the EMA website

AZ-002: Staccato alprazolam

For more information, visit www.EngageTherapeutics.com

AZ-003: Staccato FENTANYL

Cancer breakthrough pain.

AZ-007: Staccato zaleplon

Middle of the night awakening.

To discuss partnership and licensing opportunities,
please contact our Business Development Group.

ALEXZA PHARMACEUTICALS
Corporate Headquarters
2091 Stierlin Court
Mountain View, CA 94043
TEL: 650 944 7000
FAX: 650 944 7999
Email Us
Back to top